Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 212 entries
Sorted by: Best Match Show Resources per page
Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan.

BioPsychoSocial medicine

Kanazawa M, Miwa H, Nakagawa A, Kosako M, Akiho H, Fukudo S.
PMID: 27274765
Biopsychosoc Med. 2016 Jun 04;10:19. doi: 10.1186/s13030-016-0070-8. eCollection 2016.

BACKGROUND: Abdominal bloating is a common symptom in patients with irritable bowel syndrome with constipation (IBS-C). However, it is not included among the required items in the Rome III diagnostic criteria for IBS. Little is known about an impact...

Cite
Kanazawa M, Miwa H, Nakagawa A, et al. Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan. Biopsychosoc Med. 2016;10:19doi: 10.1186/s13030-016-0070-8.
Kanazawa, M., Miwa, H., Nakagawa, A., Kosako, M., Akiho, H., & Fukudo, S. (2016). Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan. BioPsychoSocial medicine, 1019. https://doi.org/10.1186/s13030-016-0070-8
Kanazawa, Motoyori, et al. "Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan." BioPsychoSocial medicine vol. 10 (2016): 19. doi: https://doi.org/10.1186/s13030-016-0070-8
Kanazawa M, Miwa H, Nakagawa A, Kosako M, Akiho H, Fukudo S. Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan. Biopsychosoc Med. 2016 Jun 04;10:19. doi: 10.1186/s13030-016-0070-8. eCollection 2016. PMID: 27274765; PMCID: PMC4893246.
Copy Download .nbib Format: NLM
Diclofenac, a nonsteroidal anti-inflammatory drug, is an antagonist of human TRPM3 isoforms.

Pharmacology research & perspectives

Suzuki H, Sasaki E, Nakagawa A, Muraki Y, Hatano N, Muraki K.
PMID: 27433342
Pharmacol Res Perspect. 2016 Apr 07;4(3):e00232. doi: 10.1002/prp2.232. eCollection 2016 Jun.

The effects of diclofenac (Dic), an acetic acid derivative-type nonsteroidal anti-inflammatory drug, were examined on the function of transient receptor potential (TRP) melastatin (TRPM) 3 (TRPM3) in human embryonic kidney 293 cell-line (HEK293) cells with recombinant human TRPM3 isoforms...

Cite
Suzuki H, Sasaki E, Nakagawa A, et al. Diclofenac, a nonsteroidal anti-inflammatory drug, is an antagonist of human TRPM3 isoforms. Pharmacol Res Perspect. 2016;4(3):e00232doi: 10.1002/prp2.232.
Suzuki, H., Sasaki, E., Nakagawa, A., Muraki, Y., Hatano, N., & Muraki, K. (2016). Diclofenac, a nonsteroidal anti-inflammatory drug, is an antagonist of human TRPM3 isoforms. Pharmacology research & perspectives, 4(3), e00232. https://doi.org/10.1002/prp2.232
Suzuki, Hiroka, et al. "Diclofenac, a nonsteroidal anti-inflammatory drug, is an antagonist of human TRPM3 isoforms." Pharmacology research & perspectives vol. 4,3 (2016): e00232. doi: https://doi.org/10.1002/prp2.232
Suzuki H, Sasaki E, Nakagawa A, Muraki Y, Hatano N, Muraki K. Diclofenac, a nonsteroidal anti-inflammatory drug, is an antagonist of human TRPM3 isoforms. Pharmacol Res Perspect. 2016 Apr 07;4(3):e00232. doi: 10.1002/prp2.232. eCollection 2016 Jun. PMID: 27433342; PMCID: PMC4876142.
Copy Download .nbib Format: NLM
A novel multimode sensor showing cation-dependent fluorescence colour.

Physical chemistry chemical physics : PCCP

Fujii S, Ishimura R, Nakagawa A, Kitamura N.
PMID: 29058743
Phys Chem Chem Phys. 2017 Nov 01;19(42):28943-28949. doi: 10.1039/c7cp05734b.

A novel sensor, 4-[2-(9-anthryl)ethynyl]-1,10-phenanthroline (1), exhibits highly intense fluorescent in the wavelength region of 440-600 nm (maximum wavelength (λ

Cite
Fujii S, Ishimura R, Nakagawa A, et al. A novel multimode sensor showing cation-dependent fluorescence colour. Phys Chem Chem Phys. 2017;19(42):28943-28949doi: 10.1039/c7cp05734b.
Fujii, S., Ishimura, R., Nakagawa, A., & Kitamura, N. (2017). A novel multimode sensor showing cation-dependent fluorescence colour. Physical chemistry chemical physics : PCCP, 19(42), 28943-28949. https://doi.org/10.1039/c7cp05734b
Fujii, Sho, et al. "A novel multimode sensor showing cation-dependent fluorescence colour." Physical chemistry chemical physics : PCCP vol. 19,42 (2017): 28943-28949. doi: https://doi.org/10.1039/c7cp05734b
Fujii S, Ishimura R, Nakagawa A, Kitamura N. A novel multimode sensor showing cation-dependent fluorescence colour. Phys Chem Chem Phys. 2017 Nov 01;19(42):28943-28949. doi: 10.1039/c7cp05734b. PMID: 29058743.
Copy Download .nbib Format: NLM
Factor structure, reliability, and validity of the Japanese version of the Hoarding Rating Scale-Self-Report (HRS-SR-J).

Neuropsychiatric disease and treatment

Tsuchiyagaito A, Horiuchi S, Igarashi T, Kawanori Y, Hirano Y, Yabe H, Nakagawa A.
PMID: 28533685
Neuropsychiatr Dis Treat. 2017 May 09;13:1235-1243. doi: 10.2147/NDT.S133471. eCollection 2017.

BACKGROUND: The Hoarding Rating Scale-Self-Report (HRS-SR) is a five-item scale that assesses the symptoms of hoarding. These symptoms include excessive acquisition, difficulty in discarding, and excessive clutter that causes distress. We conducted three studies to examine the factor structure,...

Cite
Tsuchiyagaito A, Horiuchi S, Igarashi T, et al. Factor structure, reliability, and validity of the Japanese version of the Hoarding Rating Scale-Self-Report (HRS-SR-J). Neuropsychiatr Dis Treat. 2017;13:1235-1243doi: 10.2147/NDT.S133471.
Tsuchiyagaito, A., Horiuchi, S., Igarashi, T., Kawanori, Y., Hirano, Y., Yabe, H., & Nakagawa, A. (2017). Factor structure, reliability, and validity of the Japanese version of the Hoarding Rating Scale-Self-Report (HRS-SR-J). Neuropsychiatric disease and treatment, 131235-1243. https://doi.org/10.2147/NDT.S133471
Tsuchiyagaito, Aki, et al. "Factor structure, reliability, and validity of the Japanese version of the Hoarding Rating Scale-Self-Report (HRS-SR-J)." Neuropsychiatric disease and treatment vol. 13 (2017): 1235-1243. doi: https://doi.org/10.2147/NDT.S133471
Tsuchiyagaito A, Horiuchi S, Igarashi T, Kawanori Y, Hirano Y, Yabe H, Nakagawa A. Factor structure, reliability, and validity of the Japanese version of the Hoarding Rating Scale-Self-Report (HRS-SR-J). Neuropsychiatr Dis Treat. 2017 May 09;13:1235-1243. doi: 10.2147/NDT.S133471. eCollection 2017. PMID: 28533685; PMCID: PMC5431741.
Copy Download .nbib Format: NLM
Massive Air Trapped in the Left Atrial Appendage During Catheter Ablation of Atrial Fibrillation Without a Symptomatic Air Embolism.

Journal of cardiovascular electrophysiology

Nakagawa A, Hori Y, Nakahara S, Taguchi I.
PMID: 26010936
J Cardiovasc Electrophysiol. 2015 Nov;26(11):1278. doi: 10.1111/jce.12717. Epub 2015 Jun 30.

No abstract available.

Cite
Nakagawa A, Hori Y, Nakahara S, et al. Massive Air Trapped in the Left Atrial Appendage During Catheter Ablation of Atrial Fibrillation Without a Symptomatic Air Embolism. J Cardiovasc Electrophysiol. 2015;26(11):1278doi: 10.1111/jce.12717.
Nakagawa, A., Hori, Y., Nakahara, S., & Taguchi, I. (2015). Massive Air Trapped in the Left Atrial Appendage During Catheter Ablation of Atrial Fibrillation Without a Symptomatic Air Embolism. Journal of cardiovascular electrophysiology, 26(11), 1278. https://doi.org/10.1111/jce.12717
Nakagawa, Ayako, et al. "Massive Air Trapped in the Left Atrial Appendage During Catheter Ablation of Atrial Fibrillation Without a Symptomatic Air Embolism." Journal of cardiovascular electrophysiology vol. 26,11 (2015): 1278. doi: https://doi.org/10.1111/jce.12717
Nakagawa A, Hori Y, Nakahara S, Taguchi I. Massive Air Trapped in the Left Atrial Appendage During Catheter Ablation of Atrial Fibrillation Without a Symptomatic Air Embolism. J Cardiovasc Electrophysiol. 2015 Nov;26(11):1278. doi: 10.1111/jce.12717. Epub 2015 Jun 30. PMID: 26010936.
Copy Download .nbib Format: NLM
Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study.

Hepatitis monthly

Atsukawa M, Tsubota A, Shimada N, Kondo C, Itokawa N, Nakagawa A, Hashimoto S, Fukuda T, Matsushita Y, Kidokoro H, Narahara Y, Nakatsuka K, Iwakiri K, Kawamoto C, Sakamoto C.
PMID: 24403915
Hepat Mon. 2013 Dec 23;13(12):e14872. doi: 10.5812/hepatmon.14872. eCollection 2013.

BACKGROUND: Serum vitamin D concentration is reported to show a decrease in older age. Patients with chronic hepatitis C (CHC) in Japan are older on average than those in Western countries. Moreover, the outcome of pegylated-interferon (PEG-IFN)/ ribavirin therapy...

Cite
Atsukawa M, Tsubota A, Shimada N, et al. Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study. Hepat Mon. 2013;13(12):e14872doi: 10.5812/hepatmon.14872.
Atsukawa, M., Tsubota, A., Shimada, N., Kondo, C., Itokawa, N., Nakagawa, A., Hashimoto, S., Fukuda, T., Matsushita, Y., Kidokoro, H., Narahara, Y., Nakatsuka, K., Iwakiri, K., Kawamoto, C., & Sakamoto, C. (2013). Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study. Hepatitis monthly, 13(12), e14872. https://doi.org/10.5812/hepatmon.14872
Atsukawa, Masanori, et al. "Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study." Hepatitis monthly vol. 13,12 (2013): e14872. doi: https://doi.org/10.5812/hepatmon.14872
Atsukawa M, Tsubota A, Shimada N, Kondo C, Itokawa N, Nakagawa A, Hashimoto S, Fukuda T, Matsushita Y, Kidokoro H, Narahara Y, Nakatsuka K, Iwakiri K, Kawamoto C, Sakamoto C. Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study. Hepat Mon. 2013 Dec 23;13(12):e14872. doi: 10.5812/hepatmon.14872. eCollection 2013. PMID: 24403915; PMCID: PMC3877658.
Copy Download .nbib Format: NLM
Relations between Temperament, Sensory Processing, and Motor Coordination in 3-Year-Old Children.

Frontiers in psychology

Nakagawa A, Sukigara M, Miyachi T, Nakai A.
PMID: 27199852
Front Psychol. 2016 Apr 29;7:623. doi: 10.3389/fpsyg.2016.00623. eCollection 2016.

Poor motor skills and differences in sensory processing have been noted as behavioral markers of common neurodevelopmental disorders. A total of 171 healthy children (81 girls, 90 boys) were investigated at age 3 to examine relations between temperament, sensory...

Cite
Nakagawa A, Sukigara M, Miyachi T, et al. Relations between Temperament, Sensory Processing, and Motor Coordination in 3-Year-Old Children. Front Psychol. 2016;7:623doi: 10.3389/fpsyg.2016.00623.
Nakagawa, A., Sukigara, M., Miyachi, T., & Nakai, A. (2016). Relations between Temperament, Sensory Processing, and Motor Coordination in 3-Year-Old Children. Frontiers in psychology, 7623. https://doi.org/10.3389/fpsyg.2016.00623
Nakagawa, Atsuko, et al. "Relations between Temperament, Sensory Processing, and Motor Coordination in 3-Year-Old Children." Frontiers in psychology vol. 7 (2016): 623. doi: https://doi.org/10.3389/fpsyg.2016.00623
Nakagawa A, Sukigara M, Miyachi T, Nakai A. Relations between Temperament, Sensory Processing, and Motor Coordination in 3-Year-Old Children. Front Psychol. 2016 Apr 29;7:623. doi: 10.3389/fpsyg.2016.00623. eCollection 2016. PMID: 27199852; PMCID: PMC4850168.
Copy Download .nbib Format: NLM
Blood brain barrier permeability of (-)-epigallocatechin gallate, its proliferation-enhancing activity of human neuroblastoma SH-SY5Y cells, and its preventive effect on age-related cognitive dysfunction in mice.

Biochemistry and biophysics reports

Pervin M, Unno K, Nakagawa A, Takahashi Y, Iguchi K, Yamamoto H, Hoshino M, Hara A, Takagaki A, Nanjo F, Minami A, Imai S, Nakamura Y.
PMID: 28956003
Biochem Biophys Rep. 2017 Jan 05;9:180-186. doi: 10.1016/j.bbrep.2016.12.012. eCollection 2017 Mar.

BACKGROUND: The consumption of green tea catechins (GTCs) suppresses age-related cognitive dysfunction in mice. GTCs are composed of several catechins, of which epigallocatechin gallate (EGCG) is the most abundant, followed by epigallocatechin (EGC). Orally ingested EGCG is hydrolyzed by...

Cite
Pervin M, Unno K, Nakagawa A, et al. Blood brain barrier permeability of (-)-epigallocatechin gallate, its proliferation-enhancing activity of human neuroblastoma SH-SY5Y cells, and its preventive effect on age-related cognitive dysfunction in mice. Biochem Biophys Rep. 2017;9:180-186doi: 10.1016/j.bbrep.2016.12.012.
Pervin, M., Unno, K., Nakagawa, A., Takahashi, Y., Iguchi, K., Yamamoto, H., Hoshino, M., Hara, A., Takagaki, A., Nanjo, F., Minami, A., Imai, S., & Nakamura, Y. (2017). Blood brain barrier permeability of (-)-epigallocatechin gallate, its proliferation-enhancing activity of human neuroblastoma SH-SY5Y cells, and its preventive effect on age-related cognitive dysfunction in mice. Biochemistry and biophysics reports, 9180-186. https://doi.org/10.1016/j.bbrep.2016.12.012
Pervin, Monira, et al. "Blood brain barrier permeability of (-)-epigallocatechin gallate, its proliferation-enhancing activity of human neuroblastoma SH-SY5Y cells, and its preventive effect on age-related cognitive dysfunction in mice." Biochemistry and biophysics reports vol. 9 (2017): 180-186. doi: https://doi.org/10.1016/j.bbrep.2016.12.012
Pervin M, Unno K, Nakagawa A, Takahashi Y, Iguchi K, Yamamoto H, Hoshino M, Hara A, Takagaki A, Nanjo F, Minami A, Imai S, Nakamura Y. Blood brain barrier permeability of (-)-epigallocatechin gallate, its proliferation-enhancing activity of human neuroblastoma SH-SY5Y cells, and its preventive effect on age-related cognitive dysfunction in mice. Biochem Biophys Rep. 2017 Jan 05;9:180-186. doi: 10.1016/j.bbrep.2016.12.012. eCollection 2017 Mar. PMID: 28956003; PMCID: PMC5614586.
Copy Download .nbib Format: NLM
Impact of histone deacetylase 1 and metastasis-associated gene 1 expression in esophageal carcinogenesis.

Oncology letters

Miyashita T, Tajima H, Munemoto M, Shah FA, Harmon JW, Watanabe T, Shoji M, Okamoto K, Nakanuma S, Sakai S, Kinoshita J, Makino I, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Mukaisho K, Fujimura T, Ohta T.
PMID: 25009653
Oncol Lett. 2014 Aug;8(2):758-764. doi: 10.3892/ol.2014.2176. Epub 2014 May 26.

Animal models are important for the development of novel therapies for esophageal cancer. Histone deacetylase 1 (

Cite
Miyashita T, Tajima H, Munemoto M, et al. Impact of histone deacetylase 1 and metastasis-associated gene 1 expression in esophageal carcinogenesis. Oncol Lett. 2014;8(2):758-764doi: 10.3892/ol.2014.2176.
Miyashita, T., Tajima, H., Munemoto, M., Shah, F. A., Harmon, J. W., Watanabe, T., Shoji, M., Okamoto, K., Nakanuma, S., Sakai, S., Kinoshita, J., Makino, I., Nakamura, K., Hayashi, H., Oyama, K., Inokuchi, M., Nakagawara, H., Takamura, H., Ninomiya, I., Kitagawa, H., Fushida, S., Mukaisho, K., Fujimura, T., & Ohta, T. (2014). Impact of histone deacetylase 1 and metastasis-associated gene 1 expression in esophageal carcinogenesis. Oncology letters, 8(2), 758-764. https://doi.org/10.3892/ol.2014.2176
Miyashita, Tomoharu, et al. "Impact of histone deacetylase 1 and metastasis-associated gene 1 expression in esophageal carcinogenesis." Oncology letters vol. 8,2 (2014): 758-764. doi: https://doi.org/10.3892/ol.2014.2176
Miyashita T, Tajima H, Munemoto M, Shah FA, Harmon JW, Watanabe T, Shoji M, Okamoto K, Nakanuma S, Sakai S, Kinoshita J, Makino I, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Mukaisho K, Fujimura T, Ohta T. Impact of histone deacetylase 1 and metastasis-associated gene 1 expression in esophageal carcinogenesis. Oncol Lett. 2014 Aug;8(2):758-764. doi: 10.3892/ol.2014.2176. Epub 2014 May 26. PMID: 25009653; PMCID: PMC4081431.
Copy Download .nbib Format: NLM
Evaluation of malignancy of hepatocellular carcinoma using the ultrasonic B-mode method: clinical significance of extracapsular invasion of hepatocellular carcinoma using ultrasonography.

Journal of medical ultrasonics (2001)

Nakagawara H, Ogawa M, Matsumoto N, Hiroi Y, Yamamoto T, Ono Y, Arakawa Y, Takayama T, Kinukawa N, Ishida H.
PMID: 27278291
J Med Ultrason (2001). 2007 Jun;34(2):83-91. doi: 10.1007/s10396-007-0142-2. Epub 2007 Jun 21.

PURPOSE: To determine the influence of capsule formation or presence of capsular invasion on the prognosis of hepatocellular carcinoma (HCC) patients.METHODS: The patient group consisted of 70 patients with 74 HCC lesions who had been examined by US and...

Cite
Nakagawara H, Ogawa M, Matsumoto N, et al. Evaluation of malignancy of hepatocellular carcinoma using the ultrasonic B-mode method: clinical significance of extracapsular invasion of hepatocellular carcinoma using ultrasonography. J Med Ultrason (2001). 2007;34(2):83-91doi: 10.1007/s10396-007-0142-2.
Nakagawara, H., Ogawa, M., Matsumoto, N., Hiroi, Y., Yamamoto, T., Ono, Y., Arakawa, Y., Takayama, T., Kinukawa, N., & Ishida, H. (2007). Evaluation of malignancy of hepatocellular carcinoma using the ultrasonic B-mode method: clinical significance of extracapsular invasion of hepatocellular carcinoma using ultrasonography. Journal of medical ultrasonics (2001), 34(2), 83-91. https://doi.org/10.1007/s10396-007-0142-2
Nakagawara, Hiroshi, et al. "Evaluation of malignancy of hepatocellular carcinoma using the ultrasonic B-mode method: clinical significance of extracapsular invasion of hepatocellular carcinoma using ultrasonography." Journal of medical ultrasonics (2001) vol. 34,2 (2007): 83-91. doi: https://doi.org/10.1007/s10396-007-0142-2
Nakagawara H, Ogawa M, Matsumoto N, Hiroi Y, Yamamoto T, Ono Y, Arakawa Y, Takayama T, Kinukawa N, Ishida H. Evaluation of malignancy of hepatocellular carcinoma using the ultrasonic B-mode method: clinical significance of extracapsular invasion of hepatocellular carcinoma using ultrasonography. J Med Ultrason (2001). 2007 Jun;34(2):83-91. doi: 10.1007/s10396-007-0142-2. Epub 2007 Jun 21. PMID: 27278291.
Copy Download .nbib Format: NLM
A search for Pseudomonas alginate biosynthesis inhibitors from microbial metabolites.

The Journal of antibiotics

Nakagawa A, Hosoyama T, Chubachi K, Takahashi S, Ohkubo T, Iyobe S.
PMID: 9439707
J Antibiot (Tokyo). 1997 Mar;50(3):286-8.

No abstract available.

Cite
Nakagawa A, Hosoyama T, Chubachi K, et al. A search for Pseudomonas alginate biosynthesis inhibitors from microbial metabolites. J Antibiot (Tokyo). 1997;50(3):286-8
Nakagawa, A., Hosoyama, T., Chubachi, K., Takahashi, S., Ohkubo, T., & Iyobe, S. (1997). A search for Pseudomonas alginate biosynthesis inhibitors from microbial metabolites. The Journal of antibiotics, 50(3), 286-8.
Nakagawa, et al. "A search for Pseudomonas alginate biosynthesis inhibitors from microbial metabolites." The Journal of antibiotics vol. 50,3 (1997): 286-8.
Nakagawa A, Hosoyama T, Chubachi K, Takahashi S, Ohkubo T, Iyobe S. A search for Pseudomonas alginate biosynthesis inhibitors from microbial metabolites. J Antibiot (Tokyo). 1997 Mar;50(3):286-8. PMID: 9439707.
Copy Download .nbib Format: NLM
Cushing's syndrome and big IGF-II associated hypoglycaemia in a patient with adrenocortical carcinoma.

BMJ case reports

Ishikura K, Takamura T, Takeshita Y, Nakagawa A, Imaizumi N, Misu H, Taji K, Kasahara K, Oshinoya Y, Suzuki S, Ooi A, Kaneko S.
PMID: 22461853
BMJ Case Rep. 2010;2010. doi: 10.1136/bcr.07.2009.2100. Epub 2010 Mar 30.

A 41-year-old woman had a general health examination and was diagnosed with a non-functioning adrenocortical carcinoma (ACC). Despite surgery and chemotherapy with mitotane, the ACC progressed with metastases to the lymph nodes, liver and lung. Initially, she developed adrenal...

Cite
Ishikura K, Takamura T, Takeshita Y, et al. Cushing's syndrome and big IGF-II associated hypoglycaemia in a patient with adrenocortical carcinoma. BMJ Case Rep. 2010;2010doi: 10.1136/bcr.07.2009.2100.
Ishikura, K., Takamura, T., Takeshita, Y., Nakagawa, A., Imaizumi, N., Misu, H., Taji, K., Kasahara, K., Oshinoya, Y., Suzuki, S., Ooi, A., & Kaneko, S. (2010). Cushing's syndrome and big IGF-II associated hypoglycaemia in a patient with adrenocortical carcinoma. BMJ case reports, 2010. https://doi.org/10.1136/bcr.07.2009.2100
Ishikura, Kazuhide, et al. "Cushing's syndrome and big IGF-II associated hypoglycaemia in a patient with adrenocortical carcinoma." BMJ case reports vol. 2010 (2010). doi: https://doi.org/10.1136/bcr.07.2009.2100
Ishikura K, Takamura T, Takeshita Y, Nakagawa A, Imaizumi N, Misu H, Taji K, Kasahara K, Oshinoya Y, Suzuki S, Ooi A, Kaneko S. Cushing's syndrome and big IGF-II associated hypoglycaemia in a patient with adrenocortical carcinoma. BMJ Case Rep. 2010;2010. doi: 10.1136/bcr.07.2009.2100. Epub 2010 Mar 30. PMID: 22461853; PMCID: PMC3027795.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 212 entries